Sara
Marrero Hernández
Investigadora
University of Melbourne
Melbourne, AustraliaPublicaciones en colaboración con investigadores/as de University of Melbourne (1)
2021
-
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
The Lancet Infectious Diseases, Vol. 21, Núm. 10, pp. 1383-1394